Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27943041 | 1.00 | TDP1 (0.44) | TDP1PSIP1DNM1PCSK9MEN1 | |
| SCHEMBL1286162 | 1.00 | TDP1 (0.44) | TDP1PSIP1DNM1PCSK9MEN1 | |
| SCHEMBL2839087 | 0.91 | TDP1 (0.47) | TDP1PSIP1PCSK9SMN1; SMN2CES2 | |
| SCHEMBL28530105 | 0.83 | TDP1 (0.44) | TDP1PSIP1DNM1PCSK9MEN1 | |
| SCHEMBL3412526 | 0.83 | TDP1 (0.44) | TDP1PSIP1DNM1PCSK9MEN1 | |
| SCHEMBL20904616 | 0.81 | PSIP1 (0.48) | TDP1PSIP1PCSK9TP53SMN1; SMN2 | |
| SCHEMBL7596391 | 0.80 | TDP1 (0.46) | TDP1PSIP1DNM1PCSK9CES2 | |
| SCHEMBL588204 | 0.79 | PSIP1 (0.59) | TDP1PSIP1 | |
| SCHEMBL8778748 | 0.79 | PSIP1 (0.59) | TDP1PSIP1 | |
| SCHEMBL6673936 | 0.79 | PSIP1 (0.59) | TDP1PSIP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115279905-A | Synthetic RIG-I like receptor agonists | 里珍纳龙药品有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-114269920-A | Methods and compositions for treating cancer | 儿童医疗中心有限公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-112105733-A | Synthetic RIG-I like receptor agonists | 查美特制药公司 | 2020-12-18 | — | — | CN | disclosed |
| CN-111902537-A | Modulators of DNM2 expression | IONIS制药公司 | 2020-11-06 | — | — | CN | disclosed |
| CN-111454951-A | Compositions and methods for nucleic acid-targeted nucleic acids | 卡里布生物科学公司 | 2020-07-28 | — | — | CN | disclosed |
| CN-104922699-B | Lipid formulated compositions and methods for inhibiting the expression of Eg5 and VEGF genes | 阿尔尼拉姆医药品有限公司 | 2020-07-24 | — | — | CN | disclosed |
| CN-110997906-A | B4GALT1 variants and uses thereof | 雷杰纳荣制药公司 | 2020-04-10 | — | — | CN | disclosed |